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INTRODUCTION
This proposal addresses the general goals of providing improved understanding of the pathophysiology of neurodegenerative processes affecting dopamine-secreting neurons. The research focuses on oxidative stress and damage to mitochondria evoked by the action of monoamine oxidase, and encompasses developing information that could lead to new treatment strategies for delaying or preventing the progression of Parkinson's disease. The proposal deals reversible damage to mitochondrial electron flow based on the formation of protein-disulfide linkages with oxidized glutathione (viz., protein mixed-disulfides). As described in the original Statement of Work, the proposal, in general, deals with: (1) Monoamine oxidase in the outer membrane of mitochondria within dopamine neurons; (2) Mechanisms of damage by oxidative stress, specifically that associated with role of glutathione and protein thiols in modulating the basic respiratory function of neural mitochondria; (3) Mechanisms for reversal of mitochondrial damage, and; (4) Laying the basic groundwork for new therapeutic strategies to protect against environmental neurotoxins and to prevent further dopaminergic damage in Parkinson's disease. Significant progress was made for goals (1) and (2) during the first year.
BODY OF REPORT ABBREVIATIONS USED:
This project deals with a new finding that the activity of monoamine oxidase (MAO), an outer mitochondrial membrane enzyme, alters electron flow at the inner mitochondrial membrane (Cohen, Farooqui, & Kesler, 1997) . This observation was made with both rat brain and liver mitochondria.
Electron flow, coupled to consumption of oxygen (respiration), is necessary for the production of ATP. Therefore, an implication is that the natural turnover of the neurotransmitter dopamine (DA) by MAO can affect energy production (ATP formation) and cellular viability. Parkinson's disease (PD) is characterized by an unexplained loss of DA neurons that originate in the substantia nigra, a melanized region of midbrain. It is well established that PD is itself characterized by a defect in mitochondrial respiration that targets Complex 1 activity of mitochondrial electron chain. The defect in Complex 1 is evident from autopsy studies (e.g., Schapira et al., 1990; Schapira, 1999) . The same defect characterizes PD evoked by exposure to the environmental toxin MPTP (l-methyl-4-phenyl-2,3,5,6-tetrahydropyridine) . The basis for the defect in idiopathic PD has not yet been established. However, it is believed that both genetic factors (Polymeropoulos et al., 1997; Kitada et al., 1998) and environmental toxins (Gorrell et al., 1996) may be involved.
In our working hypothesis, DA represents an "endogenous" neurotoxin. Its enhanced turnover in PD (Hornykiewicz and Kish, 1986) represents an endogenous oxidative stress evoked by MAO. The same oxidative stress can be caused by exposure to environmental neurotoxins, such as MPTP. The basic neurochemistry that underlies susceptibility of mitochondria to oxidative stress is given by the following equations: DA + 0 2 ► H 2 0 2 + NH 3 + 3,4-diOH-phenylacetaldehyde (Eqn. 1)
In this sequence, MAO produces hydrogen peroxide (H 2 0 2 , eqn. 1), an oxidative Stressor. The peroxide is removed by the enzyme glutathione (GSH) peroxidase (eqn. 2); glutathione disulfide (GSSG) is formed in the process. The GSSG then reacts with thiol groups of proteins (PrSH, eqn. 3), forming protein mixed-disulfides (PrSSG). Many proteins, including the components of Complex 1, require thiol groups for their enzymatic function. Therefore, loss of essential thiols (PrSH) via formation of PrSSG can lead to loss in enzymatic function. However, the loss is reversible; both the formation and the reversal reactions are enzymatically catalyzed.
The main research targets for the 1 st year of this grant were: (1) To determine if MAO activity suppresses mitochondrial respiration in concordance with the suppression of electron flow, (2) to determine if PrSSG levels rose simultaneously, and (3) to evaluate the actions of selective MAO-A and MAO-B substrates and inhibitors.. Progress was made in each of these critical areas. In addition, (4) we developed a new and rapid analysis for PrSSG, which will speed the work in this area. A manuscript concerning targets (1) and (2) has been accepted for publication (Cohen & Kesler, in press ), while a second manuscript concerning the new method for measuring tissue PrSSG is currently in review for publication. 
Effect of MAO activity on mitochondrial respiration:
Mitochondrial respiration is normally divided into stages or states: State 4 is achieved by the addition of substrate alone, State 3 by substrate + ADP, and State 5 (uncoupled or maximally stimulated respiration) by the addition of FCCP (carbonylcyanide p-trifluoromethoxyphenylhydrazone). The respiratory control ratios (State 3/State 4) of freshly isolated mitochondria were in the range 5.5-7.0 with 5 mM pyruvate plus 5 mM malate as substrate. State 3 respiration was in the range 72-103 ng-atoms oxygen/min/mg protein. Figure 1 shows results from experiments in which mitochondria were incubated with 500 uM tyramine, with and without MAO inhibitors, at 27°C for 15 min; 500 uM was chosen because this is the estimated level of monoamine neurotransmitter in the cytosol of catecholamine neurons (Cohen et al, 1997) . In these particular experiments, tyramine was used in place of DA in order to avoid formation of quinoidal oxidation products; tyramine cannot form quinones. However, in separate experiments. DA produced similar effects as tyramine.
State 3 and State 5 respiration were measured with pyruvate/malate (5 mM each) as substrate. Tyramine is a mixed MAO-A/MAO-B substrate (Tipton et al, 1976) ; therefore, a mixture of clorgyline (MAO-A inhibitor) and pargyline (MAO-B inhibitor) was used to inhibit MAO.
State 3 respiration was suppressed by 32.8 ± 1.7% (mean ± SEM, n=6) and State 5 respiration by 40.1% ± 1.9% (n=l 1) (pO.001) compared to the corresponding control samples without tyramine (Figure 1) . Inclusion of the MAO inhibitors (clorgyline and pargyline, 2 uM each) fully protected the mitochondria (pO.001). MAO inhibitors by themselves did not affect mitochondrial respiration (not shown).
Representative oxygen electrode tracings are presented in Figure 2 . Normally, mitochondrial respiration and synthesis of ATP are coupled on demand to the presence of ADP. Figure 2 illustrates State 3 respiration upon the addition of ADP, and State 5 respiration after uncoupling with FCCP. Figure 2 also demonstrates the diminution in both State 3 and State 5 respiration after exposure to tyramine.
Isolated mitochondria are delicate and susceptible to loss in respiratory function during incubation procedures. Therefore, samples were evaluated for the change in respiration due to the incubation conditions alone (comparison of incubated vs. non-incubated controls). The experiments with tyramine were limited to 15 min in order to limit this form of mitochondrial damage. Incubation for 15 min at 27°C decreased respiration by 27.3% ± 0.7% for State 3 and 21.7% ± 1.5% for State 5 (p<0.01, n=5/group, 2 experiments). However, the data in Figure 1 are expressed as the effects of tyramine relative to incubated controls; therefore changes due to experimental conditions, unrelated to tyramine, cancel out. Nonetheless, the loss of a highly vulnerable fraction of respiratory activity may cause the effect of tyramine to be underestimated in Figure 1 . The stock, concentrated suspension of mitochondria (15-20 mg protein/ml) in Mops buffer, held on ice, was stable and did not lose respiratory activity over the course of the experiments (3-4 hrs).
Conclusion:
These studies illustrate the direct effect of MAO activity on mitochondrial respiration and support a major premise of our research. Clearly, diminished electron flow evoked by MAO (Cohen, Farooqui, & Kesler, 1997 ) is translated into diminished respiration. In turn, this mechanism would be expected to diminish energy (ATP) production, and could form a major component of the neuronal damage evoked by environmental neurotoxins and in idiopathic PD.
Comparison of mitochondrial electron flow and respiration
We previously described the effect of incubation with tyramine, dopamine, or benzylamine, on the ability of mitochondria to reduce MTT, a formazan dye, during electron flow (Cohen et al, 1997) . Inhibition was observed when electron flow was initiated either at Complex I (pyruvate) or at Complex II (succinate); however, Complex I showed a greater susceptibility to damage. Figure 3 presents results of experiments in which inhibition of respiration and electron flow were directly compared. Tyramine had an identical effect on respiration and electron flow: Inhibition of respiration by 500 uM tyramine after 15 min was 24.6% ± 1.2%, while inhibition of electron flow was 24.7% ± 2.4%.
The respiratory data in Figure 3 were obtained in the presence of FCCP as an uncoupling agent. FCCP was also present in samples analyzed with MTT in order to make direct comparison between the two assays under comparable conditions. It is known that FCCP partially suppresses reduction of MTT by rat brain mitochondria (Liu et al., 1997) . In our experiments, FCCP diminished MTT reduction by 39.2 ± 3.4% (pO.Ol, n=6). However, direct comparison of experimental results with and without FCCP added after a 15 min exposure to tyramine indicated that inhibition of electron transport was 24.7% ± 3.0% in the presence of FCCP and 29.4% ± 1.6% in its absence (n=6/group). Therefore, the basic phenomenon was essentially the same whether or not FCCP was present. In additional experiments, results were similar when FCCP was added either prior to or after incubation with tyramine. Therefore, FCCP does not interfere with the assessment of damage to electron transport.
Conclusion:
These studies confirm that similar effects are observed when either electron flow (MTT reduction) or respiration (oxygen consumption) are evaluated.
Formation of PrSSG:
Glutathione peroxidase functions in intact mitochondria to remove H2O2 (Cf, eqn 2). GSSG, formed as the result of detoxification of MAO-generated H2O2, can react with protein thiols (Eqn. 3) to form PrSSG (Reed, 1990) . Disulfide linkages with protein would be expected to suppress thiol-dependent enzymatic activity, such as that exhibited by Complex I or pyruvate dehydrogenase. We studied the formation of PrSSG in mitochondria. The results of Figure 4 show that PrSSG levels increased rapidly and progressively during incubation of mitochondria with either tyramine or dopamine. The increase over corresponding controls after 15 min (the time at which respiration was measured) was greater than 10-fold. This observation is commensurate with secondary oxidative damage based on a change in the thiol status of proteins. MAO inhibitors completely suppressed PrSSG formation (not shown).
Conclusion:
These studies confirm a major rise in PrSSG in association with disruption of mitochondrial function.
Evaluation of selective MAO-A and MAO-B substrates and inhibitors:
DA and tyramine are mixed substrates for MAO-A and MAO-B. Studies with these substrates have generally utilized a combination of an MAO-A inhibitor (clorgyline) and an MAO-B inhibitor (deprenyl, pargyline) to suppress damage by MAO. For example, Figure 1 showed that inhibition of respiration by tyramine was completely suppressed completely by a combination of pargyline and clorgyline.
In order to better evaluate MAO-A and MAO-B, selective substrates were chosen. Serotonin was used as a selective MAO-A substrate and benzylamine as a selective MAO-B substrate. The MAO inhibitors were used at concentrations that gave selective inhibition of the appropriate form of MAO (0.2 uM). Figure 5 shows that at a concentration of 500 uM, serotonin was more powerful that benzylamine as an inhibitor of electron flow. Damage to mitochondrial electron flow by benzylamine was blocked by deprenyl (selective MAO-B DAMD 17-98-1-8624 P.I.: Gerald Cohen, Ph.D. inhibitor), but not by clorgyline (selective MAO-A inhibitor). In contrast, damage by serotonin was blocked by clorgyline, but not by deprenyl.
Conclusion:
These results verify that mitochondrial damage caused by addition of amines is due to the action of MAO. Both MAO-A and MAO-B are active in this regard, but MAO-A has the more pronounced effect. It is noteworthy that MAO-A is the form of the enzyme within DA neurons. Figure 6 is a schematic representation of the proposed mechanism for formation of PrSSG and inhibition of mitochondrial respiration. DA, tyramine, or other amines serve as substrate for MAO, which generates H2O2, inducing oxidation of GSH near the outer mitochondrial membrane. GSSG, formed by GSH peroxidase, diffuses to the inner membrane and forms PrSSG. The latter reaction is catalyzed by thioredoxins and protein disulfide isomerases. Formation of PrSSG interferes with essential enzymatic function of thiol-dependent enzymes, such as pyruvate dehydrogenase and NADH-cytochrome c reductase (Complex 1).
Summary of Mechanism of Mitochondrial Damage and Protection:
EXPERIMENTAL STUDIES: (Part II. Methodology for PrSSG):
6. Background to PrSSG assays:
As described above, this project is based, in part, on the deleterious effect of formation of PrSSG from PrSH (Cf, eqns. 1-3 & Figure 6 ) at the inner membrane of mitochondria. Measurement of PrSSG is difficult and labor-intensive. During the course of our studies, we accidentally discovered that splitting of GSH from PrSSG can be rapidly accomplished simply by treating a protein pellet with alkali at room temperature. This observation eliminates tedious processing with sodium borohydride and will speed aspects of this project.
A standard method for measuring PrSSG is that described by Akerboom and Sies (1981) and by Modig (1968) . Tissue proteins are isolated by precipitation with perchloric acid (PCA) and rinsed to remove endogenous GSH and GSSG. Then, the isolated protein is subjected to reduction with sodium borohydride (NaBH4) at neutral pH to reduce disulfide bonds and the liberated GSH is measured. We have used this method, coupled to detection of GSH with the enzymatic recycling method described by Tietze (1969) . In the course of our studies, we discovered that GSH is quantitatively liberated from PrSSG by solubilization of isolated protein pellets in alkali (0.2 M NaOH) without a need for addition of NaBH 4 . Alkali was used to fully solubilize the protein in order to ensure that reduction of disulfide linkages would be complete. With this new finding, assays for PrSSG can proceed without special precautions (related to the generation of hydrogen gas) and extra handling steps associated with the use of NaBH 4 . In essence, simply dissolving the protein pellet in alkali can be followed by immediate assay of liberated glutathione.
The validity of the new procedure for measuring PrSSG was verified as follows:
Comparison of the standard and new procedures:
For convenience, we used samples of stored tissues in which PrSSG levels had become elevated during storage. In fresh tissues, PrSSG levels are low, which makes measurement difficult. The elevated levels in stored tissue facilitated assays and the comparison of methodology. Figure 7 shows results of assays on rat brain. Results obtained by reducing PrSSG with NaBH 4 near neutral pH (procedure 1) (Akerboom & Sies, 1981 ) are compared to similar reduction carried out in 0.2M NaOH (procedure 2); in addition, the spontaneous release of GSH by 0.2 M NaOH alone (without borohydride; procedure 3) is also shown. The protein pellet was fully solubilized by alkaline solution (procedures 2 and 3), but remained as a suspension at neutral pH (procedure 1). A striking observation is that values observed after alkalinization in the absence of borohydride are not different from those with borohydride present: that is, liberation of GSH in alkaline solution took place spontaneously without a need to add NaBH4 as an external reducing agent. Values with NaOH alone were actually slightly higher (106.2% ± 1.0%) than those obtained by reduction with NaBHt at neutral pH (p<0.05).
PrSSG assays were conducted with samples of stored rat liver and brain in order to compare values obtained with NaOH alone to NaOH plus NaBH 4 (Table 1) . Results were similar whether or not NaBH 4 was added. These data show that NaBH 4 is not needed to obtain full release of GSH, and that the phenomenon is not restricted to brain tissue. 
Conclusion:
Processing with sodium borohydride is not required. GSH is quantitatively liberated from PrSSG in alkaline solution.
Kinetic parameters:
The speed of the reaction that liberates GSH from PrSSG in NaOH was assessed (Figure 8 ). Release at room temperature was remarkably rapid, yielding 50.3 ± 1.3% of maximum after only 10 seconds (the first data point).
Although the basis for PrSSG assays is that precipitation of proteins, followed by repeated sonication and recentrifugation in acidic solution, virtually eliminates free GSH from the protein pellet, the very rapid release of GSH on solubilization of the protein in alkali raised the possibility that considerable GSH was entrapped within the precipitated protein, rather than bound in a disulfide linkage. To address this issue, SDS (sodium dodecylsulfate, 1% w/v) was added to solubilize the protein at neutral pH and, then, the protein was reprecipitated with PCA and washed twice by sonication and recentrifugation. Any possible effects of residual SDS were excluded by measurements performed with internal standards of GSH (95% recovery), and by experiments in which diluted SDS (10,000-fold dilution) was added to standards (97% recovery).
Comparison of GSH released from washed protein pellets directly solubilized in 0.2 M NaOH (10.4 + 0.3 nmoles/mg protein, N=8) vs. samples previously solubilized with SDS (10.0 ± 0.5 nmoles/mg protein, N=7) yielded identical values (not significantly different, 2-tailed t-test). Therefore, the GSH released in alkaline solution represents bound glutathione and not free GSH entrapped within the protein pellet.
Comparison of PrSSG levels in fresh tissue to literature values.
Assays of fresh rat liver carried out by liberating GSH from PrSSG with 0.2 M NaOH (without NaBHO showed normal levels of 16.5 ± 2.1 nmoles/g tissue (mean ± SEM, n=4). These values compare favorably to published values of 24 ± 8 nmoles/g (mean ± SEM, n=4) reported by Higashi et al. (1985) and values in the range 15-30 nmoles/g observed by Sies et al. (1987) and Brigelius et al. (1983) .
Conclusion:
Results with the new procedure reproduce values for normal levels of PrSSG taken from the literature. This observation fully validates the new procedure.
Lack of effect of 0.2M NaOH on the stability of GSH.
GSH can undergo autoxidation to form GSSG. Because the enzymatic recycling procedure detects both GSH and GSSG, it would not be affected by conversion of GSH to GSSG. However, other methods, such as assays based on GSH-S-transferase or high performance liquid chromatography (Brigelius et al., 1983) , would be negatively affected by loss of GSH through autoxidation. Therefore, we evaluated the autoxidation of GSH in 0.2 M NaOH. To measure GSH selectively, the direct reaction with DTNB at neutral pH was used. This required higher concentrations of GSH than those used in the enzymatic-recycling assay. Incubation of 200 uM GSH in 0.2 M NaOH for 1 h, followed by dilution to 15 ug/ml in neutral buffer and subsequent assay with DTNB showed no detectable loss in GSH (98.9% ± 2.6% of control, n=5). Similar results were obtained in an experiment conducted with 1 mM GSH (98.7% ± 2.6% of control, n=6). Therefore, the material liberated in alkaline solution is amenable to assays based on the reduced form of glutathione.
Mechanism for the spontaneous liberation of GSH from PrSSG in alkaline solution.
A likely mechanism for release of GSH from PrSSG in alkaline solution is via displacement by protein thiols (PrSH) in a thiol/disulfide interchange. In alkaline solution, thiol groups are ionized and the reaction is represented by the following equation:
PrSSG + PrS--> PrSSPr + GS-(eqn. 4) The presence of a relatively high content of protein thiol groups in crude pellets isolated by acid precipitation of tissues provides the necessary reducing equivalents to liberate GSH. In liver, for example, protein thiols are present at a concentration of 94 nmoles/mg protein (Bellomo et al., 1990) , equivalent to about 9 umoles/g tissue, which is more than sufficient to react with even the high levels of 2.0-2.8 umoles PrSSG/g tissue observed in stored rat liver (Table 1) .
Conclusion:
The current study shows that the chemical reduction of disulfide bonds by externally added reducing agents, such as NaBH4 or dithiothreitol, is not necessary for the liberation of GSH from PrSSG. Liberation of GSH can be achieved simply by dissolving the protein pellet in 0.2 M NaOH, followed by an assay method of choice. In our studies, we use a variant of the enzymatic recycling method based on GSSG reductase (Tietze, 1969) , which offers high specificity and sensitivity.
METHODS:
The described studies were based on the following methods:
Rat brain mitochondria were isolated from groups of 3 Sprague-Dawley rats (250-275g) by a minor modification of the method of Clark and Nicklas (1970) . The isolation medium consisted of 5 mM Mops (3-(N-morpholino)propanesulfonic acid), containing 0.225 M mannitol, 0.075 M sucrose, and 1.0 mM EGTA, adjusted to pH 7.4 with KOH. Isolation was carried out in the cold at 15,800 x g for 10 min, followed by 15,000 x g for 30 min in the Ficoll gradient, and a final rinse at 15,800 g for 10 min. The isolated mitochondria were suspended in cold Mops buffer at a concentration of 15-20 mg mitochondria protein/ml and maintained in an ice bath until used. The yield was 3-4 mg mitochondrial protein per rat brain.
Incubations were conducted by dilution of an aliquot of the mitochondrial preparation to 0.5 mg or 1.0 mg mitochondrial protein/ml in the respiration buffer (pH 7.2), which consisted of 5 mM Hepes, 125 mM sucrose, 50 mM KC1, 2 mM KH 2 P0 4 , and 1 mM MgCl 2 with 0.5 mg bovine serum albumin/ml at 27°C. Incubations were carried out at 27°C in a volume of 1 ml in plastic tubes (12-ml) on a water bath with gentle shaking (48 oscillations/min) for 15 min. Samples were processed individually with immediate assessment of respiration and rotation among the experimental groups. Samples not incubated with MAO inhibitors received additions of the inhibitors after the incubation was complete, just prior to the measurement of respiration or electron flow. Each experiment consisted of 10-12 samples (3-4 samples per group).
Respiration was measured in a miniature 0.6 ml chamber system equipped with a magnetic stirrer and maintained at 27°C. Oxygen consumption was assessed with a Biological Oxygen Monitor (Yellow Springs Instrument Co.). Measurements were made sequentially after the addition of pyruvate/malate (5 mM each) (State 4 respiration), followed by 0.4 mM ADP (State 3) and, lastly, 10 uM FCCP (carbonylcyanide p-trifluoromethoxyphenylhydrazone; State 5). Pyruvate initiates electron flow and respiration at Complex 1. In some experiments, ADP was omitted and State 5 respiration was measured directly. Respiratory activity of the stock mitochondrial preparation, which was held on ice, was well maintained and did not change over the course of 3-4 h.
Electron flow was measured by reduction of MTT (3-(4,5-dimethylthiozol-2-yl)-2,5-diphenyltetrazolium bromide). Assays were carried out with a modification (Cohen et al., 1997) of the method described by Berridge and Tan (1993) , except that the respiration buffer was used as the medium. Samples were incubated in buffer containing pyruvate/malate (5 mM each) and MTT (0.42 mg/ml) for 5 min at 27°C and, then, the reaction was quenched by the addition of a lysing buffer consisting of 10% (w/v) sodium dodecylsulfate and 45% (v/v) dimethylformamide, adjusted to pH 4.7 with glacial acetic acid. Absorbance readings were taken in duplicate on a plate reader and reported as the difference in absorbance between 550 nm and 620 nm. Spectrophotometry was preceded by a shaking period of 99 s on the plate reader. Individual samples were expressed as a percent of the mean control value in the experiment.
PrSSG was measured with a modification of the method of Akerboom and Sies (1981) . The liberated GSH was measured on the plate reader with a modification of the enzymatic recycling method of Tietze (1969) . Details of a modified procedure are provided in the text of this report (Experimental Studies, Part II). Protein was measured by the method of Lowry et al. (1951) and was used to normalize data for both PrSSG and respiration, which were expressed per mg protein.
Data are expressed as the mean ± SEM. Statistical assessment was conducted by the Tukey-Kramer multiple comparison test or, where appropriate, by the 2-tailed Student t-test.
CONCLUSIONS:
The basic premise of this research is that the turnover of dopamine (DA) or other monoamines by monoamine oxidase (MAO) can place on oxidative stress on electron transport and respiration of mitochondria. In turn, damage to mitochondria can contribute to the progression of Parkinson's disease and to the damaging effects of environmental neurotoxins. Work conducted this past year supports the basic premise: (1) MAO activity suppresses both respiration and electron transport. (2) Formation of protein mixed disulfides (PrSSG) accompanies damage to mitochondria. (3) MAO inhibitors block both formation of PrSSG and mitochondrial damage. (4) MAO-A, the isoform of the enzyme in DA neurons, appears more active in these regards than MAO-B (glial enzyme). (5) In addition, we have developed a new and improved assay for measuring PrSSG. The new laboratory findings support the working hypothesis and help to clarify the pathophysiology of neurodegenerative mechanisms affecting DA neurons. Over the longer range, the new leads concerning thiol redox status (viz., oxidation of GSH, formation of PrSSG) can lead to improved methods to protect DA neurons from damage by environmental neurotoxins or from the ravages of Parkinson's disease.
FIGURE LEGENDS
Fig. 1. Mitochondrial respiration with pyruvate/malate (5 mM each) as substrate after incubation of samples either without (control) or with 500 uM tyramine for 15 min at 27°C. Where indicated monoamine oxidase inhibitors (MAOI) were present (2 uM clorgyline plus 2 uM pargyline) during the incubation procedure. MAO inhibitors were added to all other samples just prior to the measurement of mitochondrial respiration. For State 3 respiration, 0.4 mM ADP was added (n=6; 2 independent experiments); for State 5, 10 uM FCCP was added (n=l 1, 4 independent experiments). Statistical assessment was by ANOVA followed by the TukeyKramer multiple comparison test. *p<0.001 vs. untreated control; **p<0.001 vs. corresponding tyramine-treated samples without MAO inhibitors Release of GSH from protein mixed disulfides by NaBH 4 at neutral pH (first bar) or in 0.2 M NaOH (second bar), compared to release in 0.2 M NaOH alone (no NaBH 4 , third bar). A protein pellet was isolated from stored rat brain tissue by precipitation with PCA. The pellet was washed twice in PCA by sonication followed by centrifugation, and then it was treated as stated above. The protein pellet was subsequently reprecipitated and discarded, and the supernatant was taken for assay of GSH. Data are expressed as percent of the mean value for NaBHU at pH 7.3. Mean values are from 9-11 samples in 3 independent experiments. The mean levels of PrSSG in 3 experiments were in the range 8.5-11 nmoles GSH equivalents/mg protein. Fig. 8 . Time course for the release of GSH from PrSSG in protein pellets isolated from stored rat brain. Protein pellets were prepared as in Fig. 7 . Following the addition of 0.2 M NaOH, samples were sonicated for 10 seconds to solubilize the protein pellet and, then, samples were acidified with 0.4 M perchloric acid (final concentration) either immediately (viz., at 10 sec) or after standing for 5-30 min. Following centrifugation, the protein pellet was discarded and the supernatant was taken for assay. Data are expressed as a percent of the mean value at 30 min. Results are the mean ± SEM of 12 samples from 3 independent experiments, except for 8 samples (2 experiments) for data at 20 min. 
